ArticleInternational journal of cancer2022

Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer.

Anita Csizmarik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.